Use of oral glucocorticoids and risk of skin cancer and non-Hodgkin's lymphoma: A population-based case-control study

British Journal of Cancer

Volumn 100, Issue 1, 2009, Pages 200-205

  Jensen, A O ^a   Thomsen, H F ^a   Engebjerg, M C ^a   Olesen, A B ^a   Friis, S ^b   Karagas, M R ^c   Sorensen H T ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Case control study; Epidemiology; Non Hodgkin's lymphoma; Oral glucocorticoids; Skin cancer

Indexed keywords

GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER INCIDENCE; CANCER RISK; CHRONIC DISEASE; CONTROLLED STUDY; DATA BASE; DENMARK; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; NONHODGKIN LYMPHOMA; PRESCRIPTION; PRIORITY JOURNAL; REGISTER; SQUAMOUS CELL CARCINOMA;

ADMINISTRATION, ORAL; AGED; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; GLUCOCORTICOIDS; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MELANOMA; MIDDLE AGED; RISK FACTORS; SKIN NEOPLASMS;

EID: 58149231238     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604796     Document Type: Article

References (29)

1. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH (1999) The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 46: 263-268
2. Askling J, Klareskog L, Hjalgrim H, Baecklund E, Bjorkholm M, Ekbom A (2005) Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis. Ann Rheum Dis 64: 1765-1768
3. Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F, Catrina AI, Rosenquist R, Feltelius N, Sundstrom C, Klareskog L (2006) Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 54: 692-701
4. Dukes MNG (1993) Drug Utilization Studies: Methods and Uses. WHO Regional Publications: Geneva
5. Fox MP, Lash TL, Greenland S (2005a) A method to automate probabilistic sensitivity analyses of misclassified binary variables. Int J Epidemiol 34: 1370-1376
6. Fox MP, Lash TL, Greenland S (2005b) Boston University sensitivity analysis tools. Available at: http://sph.bu.edu/index.php?option= com_content&task=view&id=405&Itemid=508#epidemiologic
7. Frank L (2000) Epidemiology. When an entire country is a cohort. Science 287: 2398-2399
8. Frentz G (1996) General skin cancer. Quantity, treatment and quality. Ugeskr Laeger 158: 7202
9. Frentz G, Olsen JH (1999) Malignant tumours and psoriasis: a follow-up study. Br J Dermatol 140: 237-242
10. Gaist D, Sorensen HT, Hallas J (1997) The Danish prescription registries. Dan Med Bull 44: 445-448
11. Glover MT, Deeks JJ, Raftery MJ, Cunningham J, Leigh IM (1997) Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients. Lancet 349: 398
12. Greenland S (2005) Multiple-bias modeling for analysis of observational data (with discussion). J R Stat Soc 168: 267-306
13. Harre FE, Lee KL, Pollock BG (1988) Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst 80: 1198-1202
14. Jensen AO, Olesen AB, Dethlefsen C, Sorensen HT (2007) Do incident and new subsequent cases of non-melanoma skin cancer registered in a Danish prospective cohort study have different 10-year mortality? Cancer Detect Prev 31: 352-358
15. Jensen AO, Olesen AB, Dethlefsen C, Sorensen HT, Karagas MR (2008) Chronic diseases requiring hospitalization and risk of non-melanoma skin cancers - a population based study from Denmark. J Invest Dermatol 128: 926-931
16. Jensen P, Hansen S, Moller B, Leivestad T, Pfeffer P, Geiran O, Fauchald P, Simonsen S (1999) Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 40: 177-186
17. Karagas MR (1993) Are administratively collected data useful for case-control studies? Ann Epidemiol 3: 111-112
18. Karagas MR, Cushing Jr GL, Greenberg ER, Mott LA, Spencer SK, Nierenberg DW (2001) Non-melanoma skin cancers and glucocorticoid therapy. Br J Cancer 85: 683-686
19. Kinlen LJ (1992) Malignancy in autoimmune diseases. J Autoimmun 5(Suppl A): 363-371
20. Le Vay D, Loxton GE (1949) Deoxycortone acetate and ascorbic acid in the treatment of rheumatoid arthritis. Lancet 2: 1134
21. Marcen R, Pascual J, Tato AM, Teruel JL, Villafruela JJ, Fernandez M, Tenorio M, Burgos FJ, Ortuno J (2003) Influence of immunosuppression on the prevalence of cancer after kidney transplantation. Transplant Proc 35: 1714-1716
22. Nielsen GL, Sorensen HT, Weijin Z, Steffensen FH, Olsen J (1997) The Pharmacoepidemiologic Prescription Database of North Jutland - a valid tool in pharmacoepidemiological research. Int J Risk Saf Med 10: 203-205
23. Rothman KJ (2002) Epidemiology: An Introduction. Oxford University Press: New York
24. Sorensen HT, Christensen S, Mehnert F, Pedersen L, Chapurlat RD, Cummings SR, Baron JA (2008) Use of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control study. BMJ 336: 813-816
25. Sorensen HT, Mellemkjaer L, Nielsen GL, Baron JA, Olsen JH, Karagas MR (2004) Skin cancers and non-Hodgkin lymphoma among users of systemic glucocorticoids: a population-based cohort study. J Natl Cancer Inst 96: 709-711
26. Storm HH, Michelsen EV, Clemmensen IH, Pihl J (1997) The Danish Cancer Registry - history, content, quality and use. Dan Med Bull 44: 535-539
27. Szklo M, Nieto FJ (2000) Epidemiology: Beyond the Basics. Aspen: Gaithersburg, MD
28. Wacholder S, McLaughlin JK, Silverman DT, Mandel JS (1992) Selection of controls in case-control studies. I. Principles. Am J Epidemiol 135: 1019-1028
29. Zoorob RJ, Cender D (1998) A different look at corticosteroids. Am Fam Physician 58: 443-450